KCT0008733尚未招募Unknown
A single-arm phase II trial of Atezolizumab and Bevacizumab with combined radiotherapy in advanced hepatocellular carcinoma with portal vein invasion
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •(1) age =19
- •(2) clinically or histologically diagnosed HCC
- •(3) HCC with Vp2-Vp4 portal vein invasion
- •(4) intact liver function with Child-Pugh class A
- •(5) adequate size of RT field
- •(6) adequate liver function
- •; AST/ALT =5 times the upper limits of normal)
- •; no coagulopathy
- •(7) intact performance with ECOG below 2
- •(8) non-pregnant with acceptable contraception in premenopausal women)
- •(9) without other life-threatening diseases
- •(10) ability to provide written informed consent and to comply with all study conditions.
排除标准
- •(1) Active uncontrolled infection; (2) Current or history (< or = 5 years) of advanced malignancies in the other organs; (3) History of liver transplantation; (4) miliary HCC which incompatible external beam RT
研究者
相似试验
暂停
1 期
A single-arm phase II study of atezolizumab plus bevacizumab after SBRT in patients with unresectable hepatocellular carcinoma with macrovascular invasiohepatocellular carcinoma, macrovascular invasionD006528hepatocellular carcinomaJPRN-jRCTs031210694Maeda Shin36
招募中
2 期
A Phase II, single-arm trial of Atezolizumab/Platinum/Etoposide for the treatment of advanced large-cell neuroendocrine cancer of the lung (LCNEC-ALPINE)2024-515902-15-00Technische Universitaet Dresden67
进行中（未招募）
2 期
CCH1907/MK008 trialunresectable alveolar soft tissue sarcomaadvanced alveolar soft part sarcomaD018234JPRN-jRCT2031200041Yonemori Kan20
招募中
2 期
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-small-cell lung cancer patients2024-517200-10-00Fondazione Ricerca Traslazionale130
招募中
2 期
PhaseII study of Atezolizumab plus Chemotherapy in PS 2 Patients With Non-Sq NSCLCJPRN-jRCTs041210030Murakami Haruyasu20